Access to advanced techniques for studying biological materials
Official title: The Biophysics Collaborative Access Team
Funded at Illinois Institute of Technology · NIH-11009529 · Data updated 2026-11-12
This study is exploring new ways to look at proteins and other biological materials to help scientists understand diseases better, which could lead to improved treatments for conditions like heart problems.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Illinois Institute of Technology NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | February 1, 2021 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $1,095,003 |
| NIH project number | 5P30GM138395-05 |
| Project ID | NIH-11009529 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals with conditions related to protein misfolding, such as cardiomyopathies or other muscle-related diseases.
✕Less likely to help
Patients with conditions unrelated to the biophysical properties of biological materials may not receive any benefit from this research.
What this research studies
This research provides access to a cutting-edge synchrotron beamline that allows scientists to study non-crystalline biological materials through advanced diffraction and scattering techniques. Patients may benefit from the insights gained into the biophysical properties of proteins and other biological systems, which can lead to better understanding and treatment of diseases. The research employs innovative methods such as size exclusion chromatography and time-resolved X-ray diffraction to ensure high-quality data from challenging biological samples. By improving the characterization of these materials, the research aims to enhance our understanding of various health conditions, including cardiomyopathies.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic and therapeutic strategies for diseases related to protein misfolding and other biophysical anomalies.
How similar studies have gone: Other research utilizing synchrotron techniques has shown significant success in advancing our understanding of biological materials, indicating that this approach is both established and promising.
Where this research is happening
-
Illinois Institute of Technology
Chicago, United States Active
Researchers
- Principal investigator: Irving, Thomas C — Illinois Institute of Technology
- Study coordinator: Irving, Thomas C
Related research
Other NIH-funded projects on the same topics.
-
Intraoperative margin check for head and neck cancer during surgery
A new imaging and automated analysis tool is being tested during head and neck cancer surgeries to check the bottom edge of the removed tissue in under a minute.
-
Food safety research hub that collaborates to protect the public from contaminated or misrepresented foods
A large, ongoing U.S. collaboration is advancing food safety and nutrition through joint work among academia, industry, and FDA to protect consumers.
-
Identifying where harmful bacteria hide in Illinois
This grant aims to map where dangerous bacteria live in the environment in Illinois so we can stop them from getting into food.
-
Gender-affirming counseling to reduce stigma, HIV risk, and substance use in transgender women
A new program adapts Acceptance and Commitment Therapy to be led by peers, aiming to reduce internalized stigma and distress and lower substance use and HIV risk for transgender women.
-
Antibody-based targeted radiotherapy for triple-negative breast cancer
This grant aims to develop antibody chelator conjugates that deliver radioactive therapy directly to TNBC cells, potentially offering a new option for patients who have few effective treatments.
-
Gender-affirming program to reduce stigma, substance use, and HIV risk for transgender women
This program teaches gender-affirming coping skills to transgender women to reduce stigma-related distress, lower substance use, and reduce behaviors that increase HIV risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.